Bridgefront Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,529	Closed	-$116K	–	469
2022 Q4	$116K	Buy	+11,529	New	+$116K	0.08%	325
2021 Q3	–	Sell	-2,769	Closed	-$240K	–	451
2021 Q2	$240K	Buy	2,769 +153	+6%	+$13.3K	0.09%	433
2021 Q1	$216K	Buy	+2,616	New	+$216K	0.07%	549